For patients with metastatic cancer, the prognosis remains grim and conventional chemotherapy is limited. This book lays out a novel strategy using artificial intelligence and genomic data to develop precise, personalized treatments that offer hope for an eventual cure.
The treatment of cancer patients must include quality of life. As this book shows, patients do not have equal access to cancer treatment around the world, and often basic diagnosis and treatment are lacking.
This volume covers cancer epidemiology, drug development, and therapies, presenting tools to assess side effects. It also explores patient quality of life, palliative care, and the global disparities that prevent equal access to diagnosis and treatment.
In the quest for a ‘magic bullet’ against cancer, nanoparticles show great promise. These engineered nanostructures can target specific tumors, but their effectiveness must be weighed against toxicity. This book explores diverse nanotechnological advances.
The next generation of oncological hyperthermia selectively heats malignant cells. Due to its selectivity, this innovative concept is safer, less toxic, and uses significantly lower energy. This book shows the challenges, theoretical basis, and clinical results of the method.